An I2 imidazoline ligand, RS 45041, potentiates hyperalgesia in acute arthritis

NeuroReport

Volumn 7, Issue 9, 1996, Pages 1497-1501

  Houghton, Andrea K ^a   Westlund, Karin N ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Adrenoceptors; Arthritis; Idazoxan; Imidazoline receptors; Inflammation; Pain; Rat; RS 45041; RX 821002; Spinal cord

Indexed keywords

2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; ALPHA 2 ADRENERGIC RECEPTOR; CARRAGEENAN; IDAZOXAN; IMIDAZOLINE RECEPTOR; KAOLIN; RS 45041; UNCLASSIFIED DRUG; 2-METHOXYIDAZOXAN; 4 CHLORO 2 (IMIDAZOLIN 2 YL)ISOINDOLINE; 4-CHLORO-2-(IMIDAZOLIN-2-YL)ISOINDOLINE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DRUG DERIVATIVE; DRUG RECEPTOR; IMIDAZOLE DERIVATIVE; IMIDAZOLINE RECEPTORS; INDOLE DERIVATIVE;

ANIMAL EXPERIMENT; ARTHRITIS; ARTICLE; CONTROLLED STUDY; HYPERALGESIA; INFLAMMATION; INTRACEREBRAL DRUG ADMINISTRATION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; SPINAL CORD; ACUTE DISEASE; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; DRUG POTENTIATION; DRUG SCREENING; INTRASPINAL DRUG ADMINISTRATION; NERVE CELL INHIBITION; REACTION TIME; SPRAGUE DAWLEY RAT;

ACUTE DISEASE; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ARTHRITIS; DRUG EVALUATION, PRECLINICAL; DRUG SYNERGISM; HYPERALGESIA; IDAZOXAN; IMIDAZOLES; INDOLES; INJECTIONS, SPINAL; NEURAL INHIBITION; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RECEPTORS, DRUG;

EID: 0029658022     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199606170-00011     Document Type: Article

References (17)

1. Sluka KA and Westlund KN. Pain 55, 367-377 (1993).
2. Fields HL. Role of central changes in secondary hyperalgesia. In Willis WD, ed. Hyperalgesia and Allodynia. New York: Raven Press, 1992: 173-174.
3. Schaible H, Neugebauer V, Cervero F et al. J Neurophysiol 66, 1021-1032 (1991).
4. Stanfa LC and Dickenson AH. NeuroReport 5, 469-472 (1994).
5. Hylden JLK, Thomas DA, Iadarola MJ et al. Eur J Pharmacol 194, 135-143 (1991).
6. Nutt DJ, French N, Handley et al. Ann NY Acad Sci 763, 125-139 (1995).
7. Monroe PJ, Smith DL, Kirk HR et al. J Pharmacol Exp Ther 273, 1057-1062 (1995).
8. Hargreaves K, Dubner R, Brown et al. Pain 32, 77-88 (1988).
9. Brown CM, MacKinnon AC, Redfern WS et al. Br J Pharmacol 116, 1737-1744 (1995).
10. Hirata H, Pataky A, Kajander K et al. Pain 42, 253-254 (1990).
11. Sluka KA and Westlund KN. Pain 55, 217-225 (1993).
12. Harris J and Clarke RW. Eur J Pharmacol 237, 323-328.
13. MacKinnon AC, Redfern WS and Brown CM. Br J Pharmacol 116, 1729-1736 (1995).
14. Reis DJ, Li G and Regunathan S. Ann NY Acad Sci 763, 295-313 (1995).
15. Carpéné C, Collon P, Remaury A et al. J Pharmacol Exp Ther 272, 681-688 (1995).
16. Olmos G, Gabilondo AM, Miralles A et al. Br J Pharmacol 108, 597-603 (1993).
17. Pertovaara A. Prog Neurobiol 40, 691-709 (1993).